Circulating levels of CSF-1 (M-CSF) a lymphohematopoietic cytokine may be a useful marker of disease status in patients with malignant ovarian neoplasms

Barry M. Kacinski, B M Kacinski, E R Stanley, E. Richard Stanley, Darryl Carter, D Carter, J T Chambers, Joseph T. Chambers, S K Chambers, Setsuko K. Chambers, E I Kohorn, Ernest I. Kohorn, P E Schwartz, Peter E. Schwartz
International journal of radiation oncology, biology, physics · 1989 · vol. 17(1) , pp. 159–164 · doi:10.1016/0360-3016(89)90383-0 · PMID:2663797 · W2033424543
article OA: closed CC0 ⤵ 2 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This study investigated circulating CSF-1 levels as a potential marker for disease status in patients with malignant ovarian neoplasms.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Biomarkers, Tumor Colony-Stimulating Factors Ovarian Neoplasms Adenocarcinoma Adenocarcinoma Adenocarcinoma Antigens, Tumor-Associated, Carbohydrate Antigens, Tumor-Associated, Carbohydrate Biomarkers, Tumor Colony-Stimulating Factors Female Humans Macrophage Colony-Stimulating Factor Neoplasm Invasiveness Neoplasm Staging Ovarian Neoplasms Ovarian Neoplasms Predictive Value of Tests Radioimmunoassay

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (2)

References (19)

Cited by (2)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:09:10.744835+00:00
License: CC0 · commercial use OK